Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Luciana da Silva Madeira"'
Publikováno v:
Journal of Technology Management & Innovation, Vol 7, Iss 3 (2012)
The aim of this paper was to select the most interesting Brazilian biopharmaceuticals, with the best market opportunity for production. The biopharmaceuticals filgrastim, infliximab, somatropin, imiglucerase, betainterferon and factor VIII were selec
Externí odkaz:
https://doaj.org/article/e46230c09af54735aa811d3f74287d17
Autor:
Aline de Almeida Oliveira, Diana Praia Borges Freire, Ana Rodrigues de Andrade, Amanda de Miranda Marques, Luciana da Silva Madeira, José Procópio Moreno Senna, Ivna Alana Freitas Brasileiro da Silveira, Beatriz de Castro Fialho
Publikováno v:
Journal of Pharmaceutical Innovation.
PurposeAfter nearly 3 years of the COVID-19 pandemic, even though a vast body of knowledge and products (including vaccines and treatments) have been developed and disseminated, the virus is still evolving and new variants arising. Consequently, thou
Publikováno v:
Journal of Pharmaceutical Innovation
Purpose The pace of the COVID-19 vaccine development process is unprecedented and is challenging the traditional paradigm of vaccinology science. The main pressure comes from the pandemic situation, but what makes it possible is a complex set of fact
Autor:
Hugo Garcia Tonioli Defendi, Vanessa de Arruda Jorge, Ana Paula da Silva Carvalho, Suzana Borschiver, Luciana da Silva Madeira
Publikováno v:
Advances in Data Mining and Database Management
The process of knowledge construction, widely discussed in the literature, follows a common structure that encompasses transformation of data into information and then into knowledge, which converges social, technological, organizational, and strateg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55fdce5a26a3d1a44d7676fb248e956e
https://doi.org/10.4018/978-1-7998-8011-0.ch006
https://doi.org/10.4018/978-1-7998-8011-0.ch006
Autor:
Renata Chagas Bastos, Izabella Sodré Buty da Silva, Patricia Barbosa Jurgilas, Luciana da Silva Madeira, Rayane de Oliveira Guerra, Luãnna Elisa Liebscher Vidal, Kaique A. B. Pereira, Melissa Chamon Alves Premazzi, Vinícius de Lima Gonçalves
Publikováno v:
Annals of the V ISI.
Publikováno v:
Technological Forecasting and Social Change. 80:932-943
This study focuses on the patent assignments for six selected biopharmaceuticals: filgrastim, infliximab, somatropin, imiglucerase, betainterferon and factor VIII. These very expensive proteins are not currently produced in Brazil, and their producti
Publikováno v:
Anais do III Simpósio Internacional de Imunobiológicos.
Publikováno v:
Journal of Technology Management & Innovation, Vol 7, Iss 3, Pp 44-56 (2012)
Journal of technology management & innovation, Volume: 7, Issue: 3, Pages: 44-56, Published: OCT 2012
Journal of technology management & innovation v.7 n.3 2012
SciELO Chile
CONICYT Chile
instacron:CONICYT
Journal of technology management & innovation, Volume: 7, Issue: 3, Pages: 44-56, Published: OCT 2012
Journal of technology management & innovation v.7 n.3 2012
SciELO Chile
CONICYT Chile
instacron:CONICYT
The aim of this paper was to select the most interesting Brazilian biopharmaceuticals, with the best market opportunity for production. The biopharmaceuticals filgrastim, infliximab, somatropin, imiglucerase, betainterferon and factor VIII were selec
Publikováno v:
Chemosphere. 71:189-194
Its is well known that in the biodesulfurization (BDS) process the low water solubility of sulfur compounds hinders its transference from the oil phase to the cells being the rate-limiting step in the metabolism of dibenzothiophenes (DBT). Thus sulfu
Autor:
Nei Pereira, Rafael Fogel, Rafaela Rodrigues Garcia, Rebeca da Silva Oliveira, Luciana da Silva Madeira, Denise Neves Menchero Palacio
Publikováno v:
Applied Biochemistry and Biotechnology. 122:0741-0752
The dilute-acid hydrolysis of sugarcane bagasse was optimized using a statistical experimental design resulting in hydrolysates containing 57.25 g/L of xylose, which were fermented with a high inoculum concentration (10 g/L of the yeast Candida guill